Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis

被引:23
|
作者
Monz, Brigitta U. [1 ]
Sachs, Paul [2 ,3 ]
McDonald, Jeffrey [4 ]
Crawford, Bruce [5 ]
Nivens, Michael C. [6 ]
Tetzlaff, Kay [6 ,7 ]
机构
[1] Boehringer Ingelhelm GmbH, D-55216 Ingelheim, Germany
[2] Stamford Hosp, Stamford, CT 06902 USA
[3] Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA
[4] Mapi Values, Boston, MA 02114 USA
[5] Mapi Values, Tokyo 1530064, Japan
[6] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
[7] Univ Tubingen, Dept Sports Med, Med Clin, D-72076 Tubingen, Germany
关键词
Cough and sputum assessment questionnaire; COPD; Chronic bronchitis; Exacerbations; Responsiveness; OBSTRUCTIVE PULMONARY-DISEASE; SMOKING-CESSATION; TIME-COURSE; BREATHLESSNESS; VALIDATION; MANAGEMENT; RECOVERY; SYMPTOMS;
D O I
10.1016/j.rmed.2009.10.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To assess the responsiveness of the Cough and Sputum Assessment Questionnaire (CASA-Q) in COPD and chronic bronchitis patients recovering from an acute exacerbation. The 20-item questionnaire with a 7-day recall assesses the frequency and severity of cough and sputum and their impact on everyday life in clinical (trial) settings. The four domains (cough/sputum symptom and impact) use scales from 0 to 100, with lower scores indicating higher symptom/impact levels. Methods: Outpatients were enrolled within 48 h of symptom onset of their exacerbation. Treatment was initiated at the discretion of the investigator, and patients observed for 6 weeks. During study visits, 59 eligible patients completed the CASA-Q at enrolment, week 1, 2 and 6. Responsiveness was assessed by calculating standardized effect sizes. Results: Of the 19 male and 40 female patients with a mean (standard deviation, SD) age of 61.1 (10.5) years, all were classified by their physician to have improved or recovered after six weeks. The mean (SD) CASA-Qsores for the cough symptom, cough impact, sputum symptom and sputum impact domains increased from 32.6 (21.0), 40.7 (22.4), 37.4 (20.1), 47.1 (24.2) at enrolment to 54.0 (19.8), 63.7 (21.3), 55.1 (19.0), 65.5 (20.5) at week 6, respectively. Standardized effect sizes for patients improved or recovered from their exacerbation at week 6 were above 1.0 for the cough domains and at least 0.77 for the sputum domains. Conclusions: The CASA-Q was responsive to symptom changes in patients recovering from an exacerbation. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:534 / 541
页数:8
相关论文
共 50 条
  • [31] Health status during hospitalisations for chronic obstructive pulmonary disease exacerbations: the validity of the Clinical COPD Questionnaire
    Antoniu, Sabina A.
    Puiu, Alina
    Zaharia, Bogdan
    Azoicai, Doina
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (02) : 283 - 287
  • [32] Chronic cough and sputum production are associated with worse clinical outcomes in stable asthma
    Thomson, Neil C.
    Chaudhuri, Rekha
    Messow, C. Martina
    Spears, Mark
    MacNee, William
    Connell, Martin
    Murchison, John T.
    Sproule, Michael
    McSharry, Charles
    RESPIRATORY MEDICINE, 2013, 107 (10) : 1501 - 1508
  • [33] Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease
    Marc Miravitlles
    Patricia García-Sidro
    Alonso Fernández-Nistal
    María Jesús Buendía
    María José Espinosa de los Monteros
    Jesús Molina
    Health and Quality of Life Outcomes, 11
  • [35] The predictive value of the COPD assessment test (CAT) for acute exacerbations in patients with chronic obstructive pulmonary disease (COPD)
    Sajkov, Dimitar
    Huang, Ming-Shyan
    Kang, Jian
    Lin, Ching-Hsiung
    Park, Myung Jae
    Kwon, Namhee
    Lee, Sang-Do
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [36] Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies
    Snoeck-Stroband, J. B.
    Lapperre, T. S.
    Gosman, M. M. E.
    Boezen, H. M.
    Timens, W.
    ten Hacken, N. H. T.
    Sont, J. K.
    Sterk, P. J.
    Hiemstra, P. S.
    EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (01) : 70 - 77
  • [37] Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD
    Rebelo, Patricia
    Oliveira, Ana Luisa
    Paixao, Catia
    Valente, Carla
    Andrade, Lilia
    Marques, Alda
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 201 - 212
  • [38] The use of moxifloxacin for acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis
    Wilson, Robert
    Macklin-Doherty, Aislinn
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2012, 6 (05) : 481 - 492
  • [39] Relation of sputum colour to bacterial load in acute exacerbations of COPD
    Brusse-Keizer, M. G. J.
    Grotenhuis, A. J.
    Kerstjens, H. A. M.
    Telgen, M. C.
    van der Palen, J.
    Hendrix, M. G. R.
    van der Valk, P. D. L. P. M.
    RESPIRATORY MEDICINE, 2009, 103 (04) : 601 - 606
  • [40] Treatment of acute bacterial exacerbations of chronic bronchitis
    Siempos, Ilias I.
    Michalopoulos, Argyris
    Falagas, Matthew E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (07) : 1173 - 1182